Eric Bonnefoy-Cudraz Selected Research

Eric Bonnefoy-Cudraz Research Topics

Disease

22	ST Elevation Myocardial Infarction 05/2022 - 06/2012
13	Myocardial Infarction 11/2022 - 06/2015
8	Infarction (Infarctions) 01/2021 - 06/2012
7	Heart Failure 05/2022 - 06/2015
5	Non-ST Elevated Myocardial Infarction 07/2018 - 06/2015
4	Stroke (Strokes) 05/2022 - 09/2015
4	Hemorrhage 01/2021 - 06/2015
3	Thrombosis (Thrombus) 05/2021 - 04/2016
3	Inflammation (Inflammations) 01/2021 - 10/2015
2	Cardiogenic Shock 06/2021 - 01/2018
2	Chest Pain (Chest Pains) 05/2020 - 04/2016
2	Pain (Aches) 05/2020 - 04/2016
2	Reperfusion Injury 01/2017 - 09/2015
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2024
1	Ischemic Stroke 05/2022
1	Tachycardia (Tachyarrhythmias) 05/2021
1	Confusion (Bewilderment) 11/2020
1	Sepsis (Septicemia) 11/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2019
1	Cardio-Renal Syndrome 01/2019
1	Atrial Fibrillation 10/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2018
1	Coronary Occlusion 03/2016
1	Myocarditis (Carditis) 10/2015
1	Body Weight (Weight, Body) 09/2015
1	Ventricular Remodeling 09/2015
1	Unstable Angina 09/2015
1	Hypotension (Low Blood Pressure) 08/2015
1	Ischemia 06/2012
1	Edema (Dropsy) 06/2012

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 11/2021 - 10/2015
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2021 - 06/2015
3	Morphine (MS Contin)FDA LinkGeneric 05/2021 - 04/2016
3	TroponinIBA 01/2019 - 10/2016
2	AnticoagulantsIBA 10/2018 - 06/2015
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018 - 06/2012
2	GadoliniumIBA 10/2015 - 06/2012
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 02/2024
1	LipidsIBA 11/2022
1	omega-Chloroacetophenone (Mace)IBA 05/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Dobutamine FDA LinkGeneric 06/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	Colchicine FDA LinkGeneric 01/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2020
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 11/2020
1	DiureticsIBA 11/2020
1	Mineralocorticoid Receptor AntagonistsIBA 11/2020
1	Canrenoic Acid (Potassium Canrenoate)IBA 11/2020
1	PotassiumIBA 11/2020
1	Oxygen (Dioxygen)IBA 05/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 05/2020
1	Nitrous Oxide (Laughing Gas)IBA 05/2020
1	Natriuretic PeptidesIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Furosemide (Lasix)FDA LinkGeneric 01/2019
1	CreatinineIBA 01/2019
1	Neprilysin (Neutral Endopeptidase)IBA 01/2019
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2019
1	trans-crotonin (CTN)IBA 07/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	Cytochrome P-450 CYP2C19IBA 04/2016
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2016
1	Opioid Analgesics (Opioids)IBA 04/2016
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 08/2015
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2015
1	Enoxaparin (Lovenox)FDA LinkGeneric 06/2015
1	Fondaparinux (Arixtra)FDA Link 06/2015

Therapy/Procedure

16	Percutaneous Coronary Intervention 05/2022 - 06/2012
5	Therapeutics 05/2022 - 06/2012
2	Thrombectomy 05/2022 - 01/2022
2	Patient Readmission 09/2015 - 06/2015
1	Intravenous Infusions 06/2021
1	Electric Countershock (Cardioversion) 05/2021
1	Cardiac Rehabilitation 11/2020
1	Drug Therapy (Chemotherapy) 11/2020
1	Renal Dialysis (Hemodialysis) 11/2020
1	Analgesia 05/2020
1	Defibrillators (Defibrillator) 01/2019
1	Critical Care (Surgical Intensive Care) 08/2018
1	Secondary Prevention 01/2018
1	Stents 04/2016
1	Ischemic Postconditioning 11/2013